Reproducible biological functions mediated by secreted factors from stem cells in vitro and in vivo!
The 'Human Adipose Stem Cell Culture Supernatant Purified Extract (Freeze-Dried)' is a research reagent standardized for HGF (Hepatocyte Growth Factor). It is an extract of human adipose stem cell supernatant made with low toxicity through Telebio's unique technology. It can reproduce biological functions mediated by the secretory factors of stem cells both in vitro and in vivo. Two specifications are offered, with '500TBU' expected to promote higher cell proliferation. 【120TBU Specifications】 ■ Specification: 120TBU ■ Product Code: RFV2A ■ Quality Assurance Period: 3 years after manufacture ■ Classification: Research Reagent *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【500TBU Specifications】 ■Standard: 500TBU ■Product Code: RFV2A500 ■Quality Assurance Period: 3 years after manufacture ■Category: Research Reagent *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
This is a venture company established based on the stem cell research of Hirotaro Yoshimura, representing the Jichi Medical University. Through research and development of stem cells and secretome (a collective term for the factors secreted by stem cells), we are engaged in the cosmetics raw materials business, stem cell regenerative medicine business, and pharmaceutical development business. Since our founding, we have been conducting joint research with Jichi Medical University, providing evidence-based products. Starting in April 2024, we will establish a joint research course called "Department of Regenerative Medical Science," deepening our collaboration with the university. We are actively promoting joint research with academia and companies. If you are interested in joint research with us, please feel free to contact us. April 2024: We obtained a license for the manufacture and sale of first-class pharmaceuticals. License number: 13A1X10160 Date of issuance: April 12, 2024 With the acquisition of the pharmaceutical manufacturing and sales license, we are strengthening our production system by establishing a proper manufacturing management and quality control system through compliance and thorough adherence to GQP/GMP.
